BRIEF-Lexicon Pharmaceuticals says Xermelo 250 mg has been included as a recommended treatment option in latest national comprehensive cancer network
June 19, 2017 at 07:19 AM EDT
* Lexicon Pharmaceuticals Inc - Xermelo 250 mg has been included as a recommended treatment option in latest national comprehensive cancer network